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Body: The relationship between severity of obstructive sleep apnea (OSA) and kidney function was
investigated in the European Sleep Apnea Database (ESADA), where clinical, sleep, and biochemical data
of patients studied for suspected OSA in 24 sleep centres of 17 European countries are stored. After
excluding patients with missing data or extremely high/low creatinine values, data from 8112 subjects (2328
female) with creatinine values ranging between 0.5 and 2.0 mg% were analyzed. Estimated glomerular
filtration rate (eGFR) was obtained with the Modified Diet in Renal Disease (MDRD) equation. Patients were
subdivided into two groups: group 1 (n = 3709) studied by full polysomnography; group 2 (n = 4403) studied
by nocturnal cardiorespiratory monitoring. Altogether, 8.5% subjects had an eGFR<60 ml/min/1.73m2. At
univariate analysis, eGFR correlated to age, comorbidities and severity of OSA in both groups. At logistic
regression analysis, risk factors for eGFR<60 were in group 1: diabetes, female gender, age, body mass
index, and lowest nocturnal SaO2 (r2=0.086); in group 2: hypertension, female gender, age, and lowest
nocturnal SaO2 (r2=0.087). In conclusion, as expected, comorbidities, female gender and advanced age
are significant risk factors for low eGFR in subjects with OSA. While traditional severity measures of OSA
(apnea/hypopnea index, oxygen desaturation index) did not contribute to low eGFR, more severe nocturnal
hypoxia captured by lowest nocturnal SaO2 appeared as a significant predictor in this large patient cohort.
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